AAAAAA

   
Results: 1-8 |
Results: 8
Combinations of beta cell specific autoantibodies at diagnosis of diabetesin young adults reflects different courses of beta cell damage
Authors: Torn, C Landin-Olsson, M Lernmark, A Schersten, B Ostman, J Arnqvist, HJ Bjork, E Blohme, G Bolinder, J Eriksson, J Littorin, B Nystrom, L Sundkvist, G
Citation: C. Torn et al., Combinations of beta cell specific autoantibodies at diagnosis of diabetesin young adults reflects different courses of beta cell damage, AUTOIMMUN, 33(2), 2001, pp. 115-120
Glutamic acid decarboxylase antibodies (GADA) is the most important factorfor prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
Authors: Torn, C Landin-Olsson, M Ostman, J Schersten, B Arnqvist, H Blohme, G Bjork, E Bolinder, J Eriksson, J Littorin, B Nystrom, L Sundkvist, G Lernmark, A
Citation: C. Torn et al., Glutamic acid decarboxylase antibodies (GADA) is the most important factorfor prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds, DIABET M R, 16(6), 2000, pp. 442-447
The length of the CTLA-4 microsatellite (AT)(N)-repeat affects the risk for type 1 diabetes
Authors: Lowe, RM Graham, J Sund, G Kockum, I Landin-Olsson, M Schaefer, JB Torn, C Lernmark, A Dahlquist, G
Citation: Rm. Lowe et al., The length of the CTLA-4 microsatellite (AT)(N)-repeat affects the risk for type 1 diabetes, AUTOIMMUN, 32(3), 2000, pp. 173-180
Ketoacidosis in young adults is not related to the islet antibodies at thediagnosis of Type 1 diabetes mellitus - a nationwide study
Authors: Ostman, J Landin-Olsson, M Torn, C Palmer, J Lernmark, A Arnqvist, H Bjork, E Bolinder, J Blohme, G Eriksson, J Littorin, B Nystrom, L Schersten, B Sundkvist, G Wibell, L
Citation: J. Ostman et al., Ketoacidosis in young adults is not related to the islet antibodies at thediagnosis of Type 1 diabetes mellitus - a nationwide study, DIABET MED, 17(4), 2000, pp. 269-274
Prognostic factors for the course of beta cell function in autoimmune diabetes
Authors: Torn, C Landin-Olsson, M Lernmark, A Palmer, JP Arnqvist, HJ Blohme, G Lithner, F Littorin, B Nystrom, L Schersten, B Sundkvist, G Wibell, L Ostman, J
Citation: C. Torn et al., Prognostic factors for the course of beta cell function in autoimmune diabetes, J CLIN END, 85(12), 2000, pp. 4619-4623
Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes
Authors: Hampe, CS Hammerle, LP Bekris, L Ortqvist, E Kockum, I Rolandsson, O Landin-Olsson, M Torn, C Persson, B Lernmark, A
Citation: Cs. Hampe et al., Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes, J CLIN END, 85(12), 2000, pp. 4671-4679
Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies
Authors: Schranz, DB Bekris, L Landin-Olsson, M Torn, C Nilang, A Toll, A Sjostrom, J Gronlund, H Lernmark, A
Citation: Db. Schranz et al., Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies, HORMONE MET, 32(4), 2000, pp. 133-138
Species-specific autoantibodies in type 1 diabetes
Authors: Hampe, CS Ortqvist, E Rolandsson, O Landin-Olsson, M Torn, C Agren, A Persson, B Schranz, DB Lernmark, A
Citation: Cs. Hampe et al., Species-specific autoantibodies in type 1 diabetes, J CLIN END, 84(2), 1999, pp. 643-648
Risultati: 1-8 |